US Patent Issued to NUVAMID on June 2 for "Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of an antineoplastic-induced toxicity" (Swiss Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,812, issued on June 2, was assigned to NUVAMID SA (Epalinges, Switzerland).

"Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of an antineoplastic-induced toxicity" was invented by Guillaume Bermond (Epalinges, Switzerland) and Laurent Garcon (Epalinges, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Nicotinamide mononucleotide derivatives of Formula (I)for use in the treatment and/or prevention of an antineoplastic-induced toxicity. Also, pharmaceutical compositions that include compounds of Formula (I) for use in the treatment and/or prevention of an antineoplastic-induced toxicity selected from ca...